InterCure Ltd (NASDAQ:INCR) says it's the leading marijuana company outside of North America. It has reported record 2021 and first-quarter 2022 financial results. As such, INCR stock could be set to soar in value.
InterCure Begins 2022 with Record Breaking First Quarter Financial Results Record revenue of $341 million in the first quarter of 2022 Adjusted EBITDA2 increased almost. #Canndoc #INCR #InterCure